Literature DB >> 19688179

Fractal scaling properties of heart rate dynamics and myocardial efficiency in dilated cardiomyopathy.

Tiina Marjatta Salo1, Jan Sundell, Juhani Knuuti, Jukka Kemppainen, Kira Stolen, Pirjo Nuutila, Timo H Mäkikallio, Heikki V Huikuri, K E Juhani Airaksinen.   

Abstract

INTRODUCTION: Since altered heart rate (HR) fluctuations provide prognostic information in heart failure, we examined the associations between HR dynamics, myocardial efficiency and perfusion, among patients with dilated cardiomyopathy.
METHODS: Sixteen patients with dilated cardiomyopathy were enrolled. Patients received supervised strength and aerobic training for 5 months (n = 9) or standard care (n = 7). The short-term scaling exponent (alpha(1)) and frequency domain measures of HR behavior were assessed at baseline and after 5 months of intervention. The left ventricular (LV) function measured using echocardiography and oxidative metabolism measured using positron emission tomography (PET) and [(11)C]-acetate were used to estimate the myocardial efficiency.
RESULTS: Short-term fractal exponent alpha(1) correlated significantly with LV myocardial efficiency (r = 0.77, p = 0.002) at baseline. After the intervention period, the majority of patients showed improved myocardial efficiency and small or marked change in HR dynamics toward the natural fractal-like organization (alpha(1) value close 1). Parallel change in fractal properties of HR and myocardial efficiency after intervention was observed in 78% of the patients. Intervention had no significant effect on any other HR fluctuation indices.
CONCLUSIONS: The present study suggests that short-term fractal scaling exponent alpha(1), an important prognostic marker in heart failure, is related to LV myocardial efficiency.

Entities:  

Mesh:

Year:  2009        PMID: 19688179     DOI: 10.1007/s00392-009-0060-y

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  34 in total

1.  Effects of pharmacological adrenergic and vagal modulation on fractal heart rate dynamics.

Authors:  M P Tulppo; T H Mäkikallio; T Seppänen; K Shoemaker; E Tutungi; R L Hughson; H V Huikuri
Journal:  Clin Physiol       Date:  2001-09

2.  Prognostic significance of heart rate variability in dilated cardiomyopathy.

Authors:  Maciej Karcz; Lidia Chojnowska; Wojciech Zareba; Witold Ruzyłło
Journal:  Int J Cardiol       Date:  2003-01       Impact factor: 4.164

3.  Cardiac resynchronization therapy improves heart rate variability in patients with symptomatic heart failure.

Authors:  Philip B Adamson; Karen J Kleckner; Warren L VanHout; Sriram Srinivasan; William T Abraham
Journal:  Circulation       Date:  2003-07-14       Impact factor: 29.690

4.  Physiological background of the loss of fractal heart rate dynamics.

Authors:  Mikko P Tulppo; Antti M Kiviniemi; Arto J Hautala; Mika Kallio; Tapio Seppänen; Timo H Mäkikallio; Heikki V Huikuri
Journal:  Circulation       Date:  2005-07-11       Impact factor: 29.690

5.  Predicting survival in heart failure case and control subjects by use of fully automated methods for deriving nonlinear and conventional indices of heart rate dynamics.

Authors:  K K Ho; G B Moody; C K Peng; J E Mietus; M G Larson; D Levy; A L Goldberger
Journal:  Circulation       Date:  1997-08-05       Impact factor: 29.690

6.  The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Authors:  John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

7.  Adverse consequences of high sympathetic nervous activity in the failing human heart.

Authors:  D M Kaye; J Lefkovits; G L Jennings; P Bergin; A Broughton; M D Esler
Journal:  J Am Coll Cardiol       Date:  1995-11-01       Impact factor: 24.094

Review 8.  Effect of exercise training on autonomic derangement and neurohumoral activation in chronic heart failure.

Authors:  Maaike G J Gademan; Cees A Swenne; Harriette F Verwey; Arnoud van der Laarse; Arie C Maan; Hedde van de Vooren; Johannes van Pelt; Henk J van Exel; Caroline M H B Lucas; Ger V J Cleuren; Soeresh Somer; Martin J Schalij; Ernst E van der Wall
Journal:  J Card Fail       Date:  2007-05       Impact factor: 5.712

9.  Myocardial blood flow: comparison of oxygen-15-water bolus injection, slow infusion and oxygen-15-carbon dioxide slow inhalation.

Authors:  H Iida; A Takahashi; Y Tamura; Y Ono; A A Lammertsma
Journal:  J Nucl Med       Date:  1995-01       Impact factor: 10.057

10.  Early impairment of coronary flow reserve in young men with borderline hypertension.

Authors:  H Laine; O T Raitakari; H Niinikoski; O P Pitkänen; H Iida; J Viikari; P Nuutila; J Knuuti
Journal:  J Am Coll Cardiol       Date:  1998-07       Impact factor: 24.094

View more
  1 in total

1.  Short-term vs. long-term heart rate variability in ischemic cardiomyopathy risk stratification.

Authors:  Andreas Voss; Rico Schroeder; Montserrat Vallverdú; Steffen Schulz; Iwona Cygankiewicz; Rafael Vázquez; Antoni Bayés de Luna; Pere Caminal
Journal:  Front Physiol       Date:  2013-12-13       Impact factor: 4.566

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.